{"schema_version":"secwatch.filing_event.v1","accession":"0001720420-25-000008","form_type":"8-K","ticker":"IBEX","cik":"0001720420","company_name":"IBEX Ltd","filed_at":"2025-02-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.581057+00:00","generated_at":"2026-05-27T01:43:36.529140+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"IBEX Q2 revenue $140.7M (+6.1% YoY); raises FY guidance; adjusted EPS $0.59","bullets":["Q2 revenue $140.7M (+6.1% YoY); net income $9.3M (+52.6%); diluted EPS $0.57 vs $0.33 a year ago.","Adjusted EPS $0.59 (+36% YoY); adjusted EBITDA $16.5M (+15.4%); margin 11.8% vs 10.8%.","Raised FY2025 revenue guidance to $525-535M (from $515-525M); adjusted EBITDA guidance $68-69M.","Repurchased 3.6M shares from TRGI for $70M, eliminating controlled company status.","HealthTech (+31.2%) and Travel/T&L (+16.7%) drove growth; FinTech declined 14.7%."],"urls":{"canonical":"https://secwatch.observer/filing/0001720420-25-000008","json":"https://secwatch.observer/filing/0001720420-25-000008.json","markdown":"https://secwatch.observer/filing/0001720420-25-000008.md","text":"https://secwatch.observer/filing/0001720420-25-000008.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1720420/000172042025000008/0001720420-25-000008-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1720420/000172042025000008/ibex-20250206.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T01:43:36.529140+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}